Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1804313Generated: October 30, 2026

6-(2-Oxooxazolidin-3-yl)nicotinic acid methyl ester → 3-{5-[4-(3,5,6-Trimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}oxazolidin-2-one

https://huagongshe.com/reaction/1804313

Reaction equation

Participants

RoleNameHCIDCharge
Reactant6-(2-Oxooxazolidin-3-yl)nicotinic acid methyl esterHCID 58484495—
Reactant1-(3,5,6-Trimethylpyridin-2-yl)piperazine hydrochlorideHCID 67381052—
Product3-{5-[4-(3,5,6-Trimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}oxazolidin-2-oneHCID 5848450921.4%

Reaction Steps

By reaction and treatment in the same manner as in Example 63 and using 6-(2-oxooxazolidin-3-yl)nicotinic acid methyl ester (250 mg) described in Preparation Example 138 and 1-(3,5,6-trimethylpyridin-2-yl)piperazine hydrochloride (328 mg) described in Preparation Example 52 after neutralization and conversion to a free form, the title compound (95 mg) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354401B2
Source datasetuspto-grants-2013_01
ORD IDord-991e4ba0dd4146118d756ce55efd46ae
Source noteuspto-grants-2013_01